Rudd J A, Bunce K T, Naylor R J
School of Pharmacy, University of Bradford, U.K.
Neuropharmacology. 1996 Jan;35(1):91-7. doi: 10.1016/0028-3908(95)00137-9.
The potential of dexamethasone (0.5-20 mg/kg i.p.) to antagonize the emesis induced by cisplatin (10 mg/kg i.v.), apomorphine (0.25 mg/kg s.c.), morphine (0.5 mg/kg s.c.) and copper sulphate (100 mg/kg intragastric) was investigated alone and in combination with ondansetron in the ferret. There was a trend for dexamethasone 0.1-5 mg/kg to reduce cisplatin-induced emesis and for 0.05-2.5 mg/kg to delay the onset of apomorphine-induced emesis but doses of dexamethasone up to 20 mg/kg were without effect to modify morphine- or copper sulphate-induced emesis. The combination of dexamethasone 2.5 mg/kg with ondansetron 0.1 mg/kg did not have additive effects to reduce cisplatin-induced emesis but did reduce significantly the total numbers of episodes recorded. Ondansetron 1 mg/kg was without effect to modify apomorphine-, morphine- or copper sulphate-induced emesis but the combination pretreatment of ondansetron 1 mg/kg with dexamethasone 2.5 and 5 mg/kg reduced significantly apomorphine-induced retching. Data are discussed in terms of the antiemetic effectiveness of dexamethasone to antagonize chemotherapy-induced emesis in man.
研究了地塞米松(腹腔注射0.5 - 20毫克/千克)单独及与昂丹司琼联合使用时,对雪貂由顺铂(静脉注射10毫克/千克)、阿扑吗啡(皮下注射0.25毫克/千克)、吗啡(皮下注射0.5毫克/千克)和硫酸铜(胃内注射100毫克/千克)诱导的呕吐的拮抗作用。0.1 - 5毫克/千克的地塞米松有减轻顺铂诱导呕吐的趋势,0.05 - 2.5毫克/千克的地塞米松有延迟阿扑吗啡诱导呕吐发作的趋势,但高达20毫克/千克的地塞米松剂量对改变吗啡或硫酸铜诱导的呕吐无效。2.5毫克/千克的地塞米松与0.1毫克/千克的昂丹司琼联合使用对减轻顺铂诱导的呕吐没有相加作用,但确实显著减少了记录的发作总数。1毫克/千克的昂丹司琼对改变阿扑吗啡、吗啡或硫酸铜诱导的呕吐无效,但1毫克/千克的昂丹司琼与2.5毫克/千克和5毫克/千克的地塞米松联合预处理可显著减少阿扑吗啡诱导的干呕。根据地塞米松拮抗人类化疗诱导呕吐的止吐效果对数据进行了讨论。